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 Chapter 17 
 Activation of TLR3 Enhance Stemness 
and Immunomodulatory Properties 
of Periodontal Ligament Stem Cells (PDLSCs) 
 Nuttha  Klincumhom ,  Daneeya  Chaikeawkaew ,  Supanniga  Adulheem , 
and  Prasit  Pavasant 
 Abstract  Periodontal ligament stem cells (PDLSCs) have been served as a cell 
reservoir for tissue regeneration during adulthood. For clinical applications, the 
challenging steps are to maintain the stem cell properties and to improve the regen-
eration capacity of PDLSCs during culture. Toll-like receptor 3 (TLR3) signaling 
has been shown to enhance therapeutic potential in several cell types including mes-
enchymal stem cells (MSCs) by inducing the secretion of multifunctional trophic 
factors. However, the role of TLR3 in PDLSCs is still unknown. The aim of this 
study was to investigate the responses of PDLSCs after TLR3 engagement using 
TLR3 agonist, poly(I:C). The result indicated that stimulation of TLR3 signifi cantly 
enhanced pluripotent stem cell gene expression (e.g., REX-1 and SOX2) as well as 
immunomodulatory molecules (e.g., IFNγ and IDO). Interestingly, inhibition of 
NF-kB signaling decreased the TLR3-activated IFNγ but increased the TLR3- 
activated IDO expression, suggesting the multiple pathways in the inductive mecha-
nism. Our fi nding supports the concept that activated TLR3 could encourage the 
stem cell and immunosuppressive properties of PDLSCs. Since immunosuppressive 
properties of stem cells could support tissue healing and regeneration, activation of 
TLR3 in PDL cells may trigger the effective PDL tissue regeneration. 
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17.1  Introduction 
 Toll-like receptor 3 (TLR3) is a member of TLR family, the group of pattern recog-
nition receptors (PRRs) that recognizes double-stranded RNA (dsRNA) produced 
by positive-strand RNA viruses and DNA viruses, resulting in pathogen clearance 
and recruitment of adaptive immune response [ 1 ]. TLR3-dsRNA interaction gener-
ally induces the expression and secretion of IFNγ and other proinfl ammatory cyto-
kines through the Toll-interleukin-1 receptor domain-containing adaptor molecule-1 
(TICAM-1, also known as TRIF) [ 2 ]. Recent study revealed that stimulation of 
TLR3 signaling by poly(I:C), the specifi c TLR3 agonist, enhanced immunosuppres-
sive ability of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) 
through microRNA-143 inhibition [ 3 ]. Nonetheless, the therapeutic advantages of 
TLR3 activation are not only limited to its immunoregulatory response but also to 
its regenerative capacity by secretion of multifunctional trophic factors [ 4 ]. In bone 
marrow-derived MSCs (BM-MSCs), treatment with poly(I:C) potentially aug-
mented the therapeutic capability for hamster heart failure through induction of 
relevant trophic factors such as interleukin-6 (IL-6), STO-1, hepatic growth factor 
(HGF), and vascular endothelial growth factor (VEGF) [ 5 ]. 
 There is evidence suggesting that TLR3 may function as sensor to perceive the 
signal from damaged tissues upon injury. Literatures indicate that dsRNA released 
from damaged and necrotic cells can activate TLR3, resulting in an acceleration of 
the reepithelialization for wound closure. Moreover, dsRNA-induced TLR3 activa-
tion could promote the release of several cytokines including IL-6, IL-11, LIF, 
IL-10, SDF-1, VEGF, and HGF [ 6 ,  7 ]. However, the release of these cytokines is 
dependent on the type of cells and the concentration of ligand. 
 Periodontal ligament stem cells (PDLSCs) are the MSC-like cell population 
resided in periodontal ligament tissue, the connective tissue connected tooth root to 
the surrounding alveolar bone. Thus, PDLSCs have the potential to regenerate mul-
tiple cells comprising periodontal structures such as cementum, bone, and ligament 
and may pave the way for periodontal regenerative treatment via cell-based trans-
plantation [ 8 – 10 ]. Apart from regenerative properties, the potential of PDLSCs for 
therapeutic application regarding to their immune privilege and immunosuppressive 
capability has been reported recently [ 11 ]. The immunomodulatory effect of 
DAMP-activated TLR3 has been indicated in periodontopathic gingival cells by 
stimulating TLR2-mediated infl ammatory response to infected pathogen [ 12 ]. 
 It has been proposed that for tissue regeneration, three interrelated events must 
be occurred. First, our body must sense the loss of tissue integrity, followed by the 
signals to induce the migration of precursor cells to reconstitute missing structures. 
Finally, these migrating cells must be signaled for an appropriate differentiation or 
functions [ 13 ]. However, upon infection or injury of PDLSCs, the signal that trig-
gers PDLSC function for tissue regeneration has not been dignifi ed yet. In this 
study, to imitate TLR3-dsRNA recognition, poly(I:C) was used for stimulating 
TLR3 in PDLSCs. The responses of PDLSCs after poly(I:C) treatment were inves-
tigated regarding to their stemness and immunosuppressive properties. 
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17.2  Materials and Methods 
17.2.1  PDLSC Culture 
 Human PDLSCs were collected from healthy third molars as previously described 
[ 14 ]. The protocol was approved by the Ethical Committee, Faculty of Dentistry, 
Chulalongkorn University. PDLSCs were expanded in growth medium containing 
Dulbecco’s Modifi ed Eagle’s Medium supplemented with 10 % fetal bovine serum, 2 
mM L-Glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 5 μg/ml ampho-
tericin B. All cell culture reagents were purchased from Gibco BRL (Carls- bad, CA). 
Human PDLSCs were characterized for MSC properties as our previous report [ 15 ]. 
 For osteogenic differentiation, PDLSCs were cultured in osteogenic medium 
which was normal growth medium supplemented with 50 μg/ml ascorbic acid, 100 
nM dexamethasone, and 10 mM β-glycerophosphate. 
17.2.2  Poly(I:C) Treatment 
 For TLR3 activation, PDLSCs were seeded at a density of 1.2 × 10 5 cells/well in 
12-well plate in growth medium for 24 h and then treated with poly(I:C) at concen-
tration of 5, 10 and 25 μg/ml for 24 h (InvivoGen, San Diego, CA) in fresh growth 
medium. PDLSCs cultured in medium without poly(I:C) were used as control. 
17.2.3  Mineralization Assay 
 Detection of calcium deposition was evaluated on day 14 after cultured in osteo-
genic medium using the Alizarin red S staining assay. Briefl y, cells were washed 
with phosphate-buffered saline (PBS) prior to being fi xed with cold methanol for 
10 min and stained with 1 % Alizarin red S staining solution (Sigma-Aldrich, St. 
Louis, MO). 
17.2.4  Gene Expression Analysis 
 Total amount of RNA was extracted using Trizol reagent and 1 μg of RNA was con-
verted into complementary DNA (cDNA) using a reverse transcriptase enzyme kit 
(Promega, Madison, WI). Conventional PCR was performed using Taq polymerase 
(Biotechrabbit Gmbh, Hennigsdorf, Germany) in a DNA thermal cycler (Biometra 
GmH, Göttingen, Germany). The products were electrophoresed on a 2 % agarose 
gel and visualized using ethidium bromide (EtBr; Bio-Rad, Hercules, CA). 
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 qPCR was performed using SYBR GREEN FastStart Essential DNA Green 
Master which was detected by the LightCycler 96 (Roche Diagnostic GmbH, 
Mannheim, Germany). GAPDH was used as a reference gene for all experimental 
quantifi cation. The primer sequences for qPCR can be reviewed in Table  17.1 .
17.2.5  Flow Cytometry 
 PDLSCs (2 × 10 6 cells/sample) were dissociated and resuspended in 200 μl of FAC buf-
fer and stained with MSC surface marker comprised of FITC-conjugated anti- human 
CD90 (Abcam, Cambridge, MA), PE-conjugated anti-human CD105 (BD Biosciences 
 Table 17.1  Primer sequences for mRNA expression analysis (conventional PCR, qPCR) 
 Gene  Sequence 5–3′ 
 Product 
size (bp)  Sequence ID 
 GAPDH  F  5′-TGAAGGTCGGAGTCAACGGAT-3′  396  NM_002046.5 
 R  5′-TCACACCCATGACGAACATGG-3′ 
 OC  F  5′-CTTTGTGTCCAAGCAGGAGG-3′  165  NM_199173.4 
 R  5′-CTGAAAGCCGATGTGGTCAG-3′ 
 NANOG  F  5′- CAGCCCCGATTCTTCCACCAGTC-3′  389  NM_024865.3 
 R  5′- CGGAAGATTCCCAGTCGGGTTCA-3′ 
 OCT4  F  5′-GCAACCTGAGAATTTGTTCCT-3′  173  NM_002701.5 
 R  5′-AGACCCAGCAGCCTCAAAATC-3′ 
 REX1  F  5′-CAGATCCTAAACAGCTCGCAGAA-3′  305  NM_174900.4 
 R  5′-GCGTACGCAAATTAAAGTCCAGA-3′ 
 SOX2  F  5′-ACCAGCTCGCAGACCTACAT-3′  319  NM_003106.3 
 R  5′-ATGTGTGAGAGGGGCAGTGT-3′ 
 TLR3  F  5′-AAATTGGGCAAGAACTCACAGG-3′  319  NM_003265.2 
 R  5′-GTGTTTCCAGAGCCGTGCTAA-3′ 
 qOCT4  F  5′-TCGAGAACCGAGTGAGAGG-3′  124  NM_002701.5 
 R  5′-GAACCACACTCGGACCACA-3′ 
 qNANOG  F  5′-ATGCCTCACACGGAGACTGT-3′  102  NM_024865.3 
 R  5′-AAGTGGGTTGTTTGCCTTTG-3′ 
 qREX1  F  5′-TGGGAAAGCGTTCGTTGAGA-3′  89  NM_174900.4 
 R  5′-CACCCTTCAAAAGTGCACCG-3′ 
 CD73  F  5′-ACACTTGGCCAGTAAAATAGGG-3′  122  NM_002526.3 
 R  5′-ATTGCAAAGTGGTTCAAAGTCA-3′ 
 CD90  F  5′-GAAGACCCCAGTCCAGATCCA-3′  172  NM_006288.3 
 R  5′-TGCTGGTATTCTCATGGCGG-3′ 
 CD105  F  5′-CATCACCTTTGGTGCCTTCC-3′  195  NM_001114753.2 
 R  5′-CTATGCCATGCTGCTGGTGGA-3′ 
 IFNƴ  F  5′-CTAGGCAGCCAACCTAAGCA-3′  179  NM_000619.2 
 R  5′-CAGGGTCACCTGACACATTC-3′ 
 IDO  F  5′-CATCTGCAAATCGTGACTAAG-3′  187  NM_002164.5 
 R  5′-GTTGGGTTACATTAACCTTCCTT-3′ 
N. Klincumhom et al.
209
Pharmingen, San Diego, CA), and purifi ed anti-human CD73 (Abcam). For CD73 
detection, after incubating in primary antibody, cells were stained with biotinylated 
anti-mouse IgG2A followed by APC streptavidin. Stained cells will be analyzed on a 
FACSCalibur ™ using the CellQuest ™ software (BD Bioscience, San Jose, CA). 
17.2.6  Statistical Analyses 
 Data were reported as Mean ± S.D. Statistical analyses of signifi cance were evalu-
ated using a two-tailed Student’s  t -test or analysis of variance where values of 
 P < 0.05 were considered signifi cant. The analysis was performed by the statistical 
software (SPSS, Chicago, IL). A minimum of three replicates were analyzed for 
each experiment. 
17.3  Results and Discussion 
 In periodontitis, the unhealthy cells of sulcular epithelium as well as gingival tissue 
were damaged either from the effect of proinfl ammatory cytokines or from mechan-
ical stimulation such as chewing or brushing [ 16 ]. As in skin wound healing that 
was reported previously, the damaged or dying cells could release dsRNA, resulting 
in the activation of TLR3 and subsequently initiating tissue regeneration [ 17 ]. In 
this case, damaged cells in periodontitis may activate TLR3 in PDLSCs leading to 
the healing and regeneration of periodontal tissue. 
17.4  TLR3 Activation Promote Stemness of PDLSCs 
 Human PDLSCs isolated from PDL tissue expressed the MSC markers including 
CD73, CD90 and CD105, as well as pluripotent markers such as REX-1, OCT4, 
NANOG, and SOX2. They also exhibited osteogenic characteristic as presented in 
upregulation of osteocalcin (OC) mRNA level and calcium deposition after osteo-
genic induction (Fig.  17.1 ). These results support that our isolated PDL cells pos-
sess stem cell characteristics, referred as PDLSCs.
 Next, we examined the expressions of TLR2-4 in PDL tissue and PDLSCs. PDL 
tissue and dental pulp and gingival tissues from healthy patients were obtained with 
informed consent and subjected to RT-PCR analysis for the detection of TLR2-4 
expressions. The results indicated that the expression levels of TLR2-4 were 
detected differently depended on cell types. Our study found that PDL tissue 
expressed the highest level of TLR3 compared to cells from dental pulp and gingiva. 
Moreover, gingival tissue showed the highest level of TLR2. No difference in 
expression of TLR4 was observed among tissue types (Fig.  17.2a ).
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 As shown in Fig.  17.2 , PDLSC itself promptly expressed TLR3. Poly(I:C) was 
used as specifi c TLR3 ligand to stimulate TLR3 function in PDLSCs. Cells were 
treated with poly(I:C) at concentration of 5, 10, and 25 μg/ml for 24 h. Our result 
showed the signifi cant increased in mRNA levels of MSC-specifi c surface markers, 
CD73 and CD105, and the self-renewal markers REX-1 and SOX2 as compared to 
untreated control. No signifi cant difference among poly(I:C)-treated groups was 
presented (Fig.  17.3a, b ). Our result which corresponds with recent study indicated 
that activation of TLR3 by poly(I:C) promoted the cancer stem cell phenotype by 
upregulating the pluripotent genes including SOX2 in breast cancer [ 18 ]. Moreover, 
the increased mRNA level of hair progenitor-specifi c marker has been observed 
upon TLR3 activation in keratinocyte which contributed to hair follicle regeneration 
[ 17 ]. Attractively, TLR3 activation was required for induction of pluripotency in 
fi broblast by modifi cation of epigenetic mechanism [ 19 ].
 We imply that TLR3 may serve as a trigger receptor for damaged/infected response 
by enhancing the stemness of PDLSCs. Further determining of the signaling that 
involved in TLR3-acivated stem cell properties in PDLSCs would be needed to pro-
vide the better understanding of underlying mechanism of regeneration upon infection 
or injury. Besides, there are studies showing that the proliferation and differentiation 
capacities of PDLSCs had been weakened during in vitro culture expansion or in aged 
donors-derived, resulting in loss of proliferative and regenerative capacity [ 20 ,  21 ]. 
Here, we suggest that enhancement of PDLSC stemness by poly(I:C) treatment could 
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 Fig. 17.1  Human PDL cells possessed the MSC characteristics. Human PDL cells were estab-
lished from periodontal tissue obtained from extracted third molars. Cells from passage 3 were 
analyzed for the expression of mesenchymal stem cell markers. The results from FACS analysis 
showed that more than 90 % of cells expressed CD73, CD90, and CD105 ( a ). HPDL cells also 
expressed pluripotent markers such as Rex-1, Oct4, nanog, and Sox2 as judged by RT-PCR ( b ). For 
osteogenic differentiation ability, cells were cultured in osteogenic medium for 14 days. The 
increased expression of osteocalcin ( OC ) was detected. Moreover, in vitro calcifi cation was 
observed as judged by alizarin red S staining ( c ). The fi gure was the representative results from 
three established PDL cell lines 
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17.5  TLR3 Activation Enhance Immunosuppressive 
Properties of PDLSCs 
 The MSC-like phenotypes of PDLSCs are not only the expression of stem cell 
markers, but also the immunosuppressive activity that can suppress immune 
responses after allogeneic transplantation [ 11 ]. The immune response interference 
of PDLSCs is generally processed through a cell-cell contact and secretion of 
immunomodulatory factors resulting in inhibition of T and B cell proliferation. 
Additionally, recent study indicated the immunosuppressive activity of PDLSCs is 
resisted even after osteogenic differentiation [ 22 ]. 
 The role of TLR3 regarding the immunomodulation properties has been examined 
extensively in MSCs derived from several origins such as BM-MSCs [ 5 ], AD-MSCs 
[ 23 ], and UC-MSCs [ 3 ]; however, no comprehensive study in dental stem cells has 
been studied. In present study, after exposing to 25 μg/ml of poly(I:C) for 24 h, the 
upregulation of immunomodulatory mRNA levels, IFNγ, and IDO in PDLSCs was 
detected by qPCR (Fig.  17.4a ). IFNγ is known as an upstream regulator of immuno-
modulatory molecules in MSCs. These cytokines promote an IDO production, result-
ing in restoring immunosuppressive ability of dental pulp stem cells (DPSCs) derived 
from irreversible pulpitis [ 24 ]. IDO is a catalytic enzyme of tryptophan, a crucial 
 Fig. 17.2  Expression of TLR3 in periodontal tissue and PDL cells. Periodontal ( PDL ), dental pulp 
(pulp), and gingiva tissues were obtained from healthy patient and subject for RT-PCR analysis. 
The results ( a ) showed that all three tissues expressed TLR2, TLR3, and TLR4 with different 
levels. The highest expression of TLR3 was found in PDL tissue while gingiva expressed the high-
est level of TLR2. ( b ) showed the expression of TLR3 from three PDL cell lines ( a – c ). GAPDH 
was used as the internal control 
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 Fig. 17.3  Poly(I:C) enhanced the expression of stem cell markers in human PDL cells. Human 
PDL cells were treated with poly(I:C) at concentration of 5, 10 and 25 μg/ml for 24 h. Real-time 
RT-PCR analysis showed that poly(I:C) enhanced the expression of MSC markers; CD73, CD105 
( a ), and pluripotent markers; Rex-1, Sox2 ( b ). * indicated the signifi cant difference ( p < 0.05). The 
results were shown as mean ± S.D. from three experiments 
 
N. Klincumhom et al.
213
amino acid for T cell growth. Upregulation of IDO thus leads to the inhibition of T cell 
proliferation [ 25 ,  26 ]. In AD-MSCs, IDO is secreted in conditioned supernatant by 
IFNγ and potentially inhibited PBMC proliferation. Previous study indicated immu-
nosuppressive mechanism of TLR3 in UC-MSCs through inhibiting microRNA-143 
that results in IDO production [ 23 ]. We therefore denote that activation of TLR3 pro-
motes immunosuppressive properties of PDLSCs via stimulating IFNγ and IDO. It 
has been shown that upon injury or infl ammation of tissue, the immunosuppressive 
cytokines released from MSCs indicated to play a role in tissue homeostasis by inhib-
iting infl ammatory response as well as stimulating the proliferation and differentiation 
of stem/progenitor cells [ 27 ]. By this cell protective mechanism, we prospect that 
activation of PDLSCs to secrete these immunosuppressive cytokines could augment 
the therapeutic potential of MSCs for tissue regeneration.
17.6  TLR3 Activation Induces IFNγ Production in PDLSCs 
Via NF-kB Pathway 
 Normally, released dsRNA after viral infection is recognized by TLR3, and then 
activate NF-kB signaling, through TIR domain-containing adaptor TRIF [ 28 ,  29 ]. 
To examine whether activation of TLR3 in PDLSCs regulates production of IFNγ 
and its downstream IDO via NF-kB signaling, the NF-kB inhibitor was added into 
 Fig. 17.4  TLR3 activation induced immunosuppressive property of human PDL cells. Human 
PDL cells were treated with 25 μg/ml poly(I:C) for 24 h. RT-PCR analysis revealed that poly(I:C) 
signifi cantly induced the expression of IFNγ and IDO ( a ). Addition of NF-kB inhibitor inhibited 
the poly(I:C)-induced IFNγ but could not inhibit the induction of IDO ( b ). Moreover, poly(I:C)-
induced stem cell markers were also NF-kB independent ( c ,  d ). * indicated the signifi cant differ-
ence ( p < 0.05). The results were shown as mean ± S.D. from three experiments 
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normal medium with and without poly(I:C) treatment. The mRNA expression of 
immunomodulatory molecules IFNγ and IDO was determined using qPCR. The 
result showed that, without poly(I:C) treatment, NF-kB inhibitor did not affect the 
endogenous IFNγ and IDO in PDLSCs. Interestingly, pretreatment of NF-kB inhib-
itor could attenuate the induction of IFNγ while further increasing IDO expression 
when compared to those in poly(I:C) treatment alone (Fig.  17.4b ). Typically, IDO is 
induced by IFNγ in dendritic cells and macrophages. However, the regulation of 
IDO expression via IFNγ-independent pathways has been reported previously in 
astrocyte [ 30 ]. The result revealed that TLR3 activates IFNγ production in PDLSCs 
via NF-kB signaling, while TLR3-activated IDO expression may be possessed by 
other NF-kB-independent pathways. 
 Additionally, TLR3-activated NF-kB nuclear translocation has been reported to 
play an important role in epigenetic mechanisms during reprogramming of fi bro-
blast into induced pluripotent stem cells (iPSCs) via retrovirus encoding reprogram-
ming factors [ 19 ]. Therefore, it is possible that TLR3-induced stemness of PDLSCs 
was regulated via NF-kB signaling. To test this idea, the mRNA expression of plu-
ripotent stem cell markers (e.g., REX-1 and SOX2) and MSC markers (e.g., CD73 
and CD105) of TLR3-activated PDLSCs was determined after pretreatment with 
NF-kB inhibitor using qPCR. We found that addition of NF-kB inhibitor had no 
effect on the induction of those stem cell markers in either with poly(I:C) activation 
or NF-kB inhibitor alone in PDLSCs (Fig.  17.4c, d ), though more studies are 
required for better understanding on how TLR3 signaling regulates stemness in 
PDLSCs. 
17.7  Conclusion 
 In summary, our study discovered that TLR3 engagement by its specifi c ligand 
poly(I:C) could stimulate the stem cell properties of PDLSCs including self-renewal 
and immunomodulation. In periodontitis, it is possible that PDLSCs might generate 
new cells and prevent the immune cell-initiated infl ammation for repairing the dam-
aged structure through these mechanisms. Hence, TLR3 agonist may be a novel 
approach to enhance stem cell properties of PDLSCs for tissue regeneration, espe-
cially allogeneic cell-based therapy. 
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